UCHL1 and Alzheimer disease: The APP/PS1 mouse model of AD, which overproduces Aβ, shows similar redistribution of soluble and insoluble UCH-L1 to that observed in human AD brain, with a reported ∼20% reduction of in vitro hydrolytic activity [95].